Endoscopy | Bladder Biopsy & Tumor Resection (TURBT)

Executive Summary

TransUrethral Resection of Bladder Tumor (TURBT) is a commonly performed, minimally invasive type of urology surgery necessary to remove tumors present in the lining of the bladder. Most bladder tumors are cancerous. The goals of the surgery are curative (to try and remove all the tumor) as well as diagnostic (tissue is sent for microscopic analysis to confirm a diagnosis). TURBT is the first step in making a diagnosis and establishing risk.

A cut on the skin is not required since the surgery is done with an instrument inserted through the urethra. The vast majority of patients are admitted to the hospital the same day as the surgery and discharged home later that same day. Some patients will require a temporary catheter. Some patients will receive chemotherapy administered into the bladder at the time of their surgery.

All patients will have some blood in the urine after surgery and will have urinary symptoms including urgency to void, frequency and burning. These side-effects are temporary, usually lasting a few days. Serious complications are uncommon.

Background

Most tumors arising from the bladder are cancerous and the most common type of bladder cancer by far is transitional cell carcinoma (also known as urothelial carcinoma). These most commonly present with blood in the urine (the blood may not always be visible to the naked eye). Non-cancerous (benign) tumors may also require TURBT. In virtually all cases, histologic examination of a sample of the bladder tumor under a microscope is necessary to establish a diagnosis. There is no substitute for obtaining bladder tissue to establish a diagnosis.

Why Transurethral Resection of Bladder Tumor?

TURBT is indicated for diagnostic and therapeutic purposes as described above. What variations exist between different surgical approaches are minor and clinically insignificant. We offer offer monopolar and bipolar TURBT and will determine which is most suitable on the individual clinical scenario.

Before and Immediately After Surgery

This describes the process of surgery from your pre-operative assessment through to discharge. Please review the information on General Advice for activity and travel after surgery.

TURBT has a favorable risk profile and a reasonably quick recovery in most patients. However, the bladder is thin walled and highly vascular. However, in the course of obtaining an adequate sample and an attempt remove the tumor in order to achieve a cure, perforation, bleeding and other serious complications may occur. Patients almost always accept these risks as untreated bladder cancer may be lethal.

Short and Long Term Risks

This describes what to expect after you leave the hospital.

Temporary changes in urination are expected following surgery and will gradually improve over 3-6 weeks. The irritative symptoms (urgency, frequency) tend to settle quickly in the first few weeks.

Minor, self-limited complications or those requiring minimal intervention occur in approximately 1 in 10 patients. Serious complications as defined by a need to return to the operating room occur in about 1 in 50 patients and most commonly involve a trip to the operating room to evacuate clot or address recurrent bleeding.

Proceed to the Emergency Room and contact us if any of the following occur:

  • Catheter is not draining or you are unable to urinate after the catheter is removed.

  • Fever over 38.5 C.

  • Severe pain, nausea or vomiting unrelieved by medication.

  • Leg pain or swelling.

Please see our section on Catheter Care if you are sent home with a catheter.

What to Do After Surgery

This explains what patients can expect after discharge home and how to optimize recovery.

On the Web